Judge Sets Deadline for Post-Trial Briefs In Zyprexa Case
A federal judge has given both sides in the patent trial over Eli Lilly's Zyprexa schizophrenia drug until May 12 to file all of their post-trial briefs....To view the full article, register now.
Already a subscriber? Click here to view full article